Glycogen synthase kinase-3β contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-D-aspartate receptor trafficking

Anesthesia and Analgesia

Volumn 116, Issue 2, 2013, Pages 473-481

  Yuan, Yuan ^a   Wang, Jing Yao ^a   Yuan, Fang ^a   Xie, Ke Liang ^a   Yu, Yong Hao ^a   Wang, Guo Lin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; REMIFENTANIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HYPERALGESIA; LATENT PERIOD; LUMBAR SPINAL CORD; MALE; MECHANICAL STIMULATION; NONHUMAN; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKIN INCISION; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; BLOTTING, WESTERN; GLYCOGEN SYNTHASE KINASE 3; HOT TEMPERATURE; HYPERALGESIA; MALE; PAIN, POSTOPERATIVE; PHYSICAL STIMULATION; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SPINAL CORD; THIADIAZOLES;

EID: 84872846956     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318274e3f1     Document Type: Article

References (36)

1. Célèrier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci 2001;21:4074-80
2. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000;92:465-72
3. Albrecht S, Fechner J, Geisslinger G, Maass AB, Upadhyaya B, Moecke H, Haigh C, Schüttler J. Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery. Anaesthesia 2000;55:315-22
4. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Shortterm infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003;106:49-57
5. Bürkle H, Dunbar S, Van Aken H. Remifentanil: a novel, shortacting, mu-opioid. Anesth Analg 1996;83:646-51
6. Fletcher D, Pinaud M, Scherpereel P, Clyti N, Chauvin M. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg 2000;90:666-71
7. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-5
8. Luginbühl M, Gerber A, Schnider TW, Petersen-Felix S, Arendt-Nielsen L, Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 2003;96:726-32
9. Yarmush J, D'Angelo R, Kirkhart B, O'Leary C, Pitts MC II, Graf G, Sebel P, Watkins WD, Miguel R, Streisand J, Maysick LK, Vujic D. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology 1997;87:235-43
10. Stephenson FA. Subunit characterization of NMDA receptors. Curr Drug Targets 2001;2:233-9
11. Dunah AW, Standaert DG. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 2001;21:5546-58
12. Kennedy MJ, Ehlers MD. Organelles and trafficking machinery for postsynaptic plasticity. Annu Rev Neurosci 2006;29:325-62
13. Groc L, Choquet D. AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res 2006;326:423-38
14. Pérez-Otaño I, Ehlers MD. Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 2005;28:229-38
15. Aanonsen LM, Wilcox GL. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 1987;243:9-19
16. Advokat C, Rhein FQ. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res 1995;699:157-60
17. Bespalov A, Kudryashova M, Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eur J Pharmacol 1998;351:299-305
18. Célèrier E, Laulin J, Larcher A, Le Moal M, Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res 1999;847:18-25
19. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987;26:1235-8
20. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 1990;9:2431-8
21. Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B, Przewlocki R. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther 2006;319:832-9
22. Chen P, Gu Z, Liu W, Yan Z. Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons. Mol Pharmacol 2007;72:40-51
23. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10
24. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996;64:493-501
25. Cui W, Li Y, Li S, Yang W, Jiang J, Han S, Li J. Systemic lidocaine inhibits remifentanil-induced hyperalgesia via the inhibition of cPKCgamma membrane translocation in spinal dorsal horn of rats. J Neurosurg Anesthesiol 2009;21:318-25
26. Massimo C, Christoph T, Raffaella M, Margherita G, Elisa B, Gianluca M, Sara C, Oliviero D, Oliver M, Chiara D, Manuela A, Roberto F. Treatment with the glycogen synthase kianse-3? inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 2008;30:299-307.
27. Livak KJ.comparative Ct method. User Bulletin No. 2: ABI Prism 7700 Sequence Detection System. Carlsbad, CA: PE Applied Biosystems, 1997
28. Brennan TJ, Zahn PK, Pogatzki-Zahn EM. Mechanisms of incisional pain. Anesthesiol Clin North Am 2005;23:1-20
29. Célérier E, González JR, Maldonado R, Cabañero D, Puig MM. Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology 2006;104:546-55
30. Gu X, Wu X, Liu Y, Cui S, Ma Z. Tyrosine phosphorylation of the N-methyl-D-aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine. Mol Pain 2009;5:76
31. Cabañero D, Campillo A, Célérier E, Romero A, Puig MM. Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 2009;111:1334-45
32. Wang S, Zhang L, Ma Y, Chen L, Tian Y, Mao J, Martyn JJ. Nociceptive behavior following hindpaw burn injury in young rats: response to systemic morphine. Pain Med 2011;12: 87-98
33. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 2007;53: 703-17
34. LacKamp A, Zhang GC, Mao LM, Fibuch EE, Wang JQ. Loss of surface N-methyl-D-aspartate receptor proteins in mouse cortical neurones during anaesthesia induced by chloral hydrate in vivo. Br J Anaesth 2009;102:515-22
35. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schüttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99:152-9
36. Zhao M, Joo DT. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 2008;109:308-17